Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Craig

Showing results (141-150 of 199) with videos related to

Pageof 20
Sort By:
Molecular Pharmacology|September 1, 1990
Interferon down regulates the male-specific cytochrome P450IIIA2 in rat liverP I Craig, I Mehta, M Murray, et al.
Journal of the National Cancer Institute|July 21, 2005
Criterion validity of Medicare chemotherapy claims in Cancer and Leukemia Group B breast and lung cancer trial participantsElizabeth B Lamont, James E Herndon, Jane C Weeks, et al.
The American Journal of Gastroenterology|December 6, 2017
Novel Intra-Procedural Distensibility Measurement Accurately Predicts Immediate Outcome of Pneumatic Dilatation for Idiopathic AchalasiaP I Wu, M M Szczesniak, P I Craig, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1987
Isolation and characterization of a steroid sulfatase cDNA clone: genomic deletions in patients with X-chromosome-linked ichthyosisA Ballabio, G Parenti, R Carrozzo, et al.
Archives of Virology|June 19, 2014
First report of isolation and molecular characterization of bubaline herpesvirus 1 (BuHV1) from Argentinean water buffaloesSilvina S Maidana, José L Konrad, María I Craig, et al.
Medical Care|April 5, 2008
Measuring clinically significant chemotherapy-related toxicities using Medicare claims from Cancer and Leukemia Group B (CALGB) trial participantsElizabeth B Lamont, James E Herndon, Jane C Weeks, et al.
The Journal of Infection|January 1, 1982
Rotavirus infections in a special-care baby unitA S Bryden, M E Thouless, C J Hall, et al.
Journal of the National Cancer Institute|September 21, 2006
Measuring disease-free survival and cancer relapse using Medicare claims from CALGB breast cancer trial participants (companion to 9344)Elizabeth B Lamont, James E Herndon, Jane C Weeks, et al.
Australian and New Zealand Journal of Medicine|June 1, 1991
Can the response to interferon treatment be predicted in patients with chronic active hepatitis C?R Lin, M N Schoeman, P I Craig, et al.
Gastrointestinal Endoscopy|September 27, 2017
Role of capsule endoscopy and fecal biomarkers in small-bowel Crohn's disease to assess remission and predict relapseVipul Aggarwal, Andrew S Day, Susan Connor, et al.
Pageof 20

Showing results (141-150 of 199) with videos related to

Sort By:
Pageof 20
Molecular Pharmacology|September 1, 1990
Interferon down regulates the male-specific cytochrome P450IIIA2 in rat liverP I Craig, I Mehta, M Murray, et al.
Journal of the National Cancer Institute|July 21, 2005
Criterion validity of Medicare chemotherapy claims in Cancer and Leukemia Group B breast and lung cancer trial participantsElizabeth B Lamont, James E Herndon, Jane C Weeks, et al.
The American Journal of Gastroenterology|December 6, 2017
Novel Intra-Procedural Distensibility Measurement Accurately Predicts Immediate Outcome of Pneumatic Dilatation for Idiopathic AchalasiaP I Wu, M M Szczesniak, P I Craig, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1987
Isolation and characterization of a steroid sulfatase cDNA clone: genomic deletions in patients with X-chromosome-linked ichthyosisA Ballabio, G Parenti, R Carrozzo, et al.
Archives of Virology|June 19, 2014
First report of isolation and molecular characterization of bubaline herpesvirus 1 (BuHV1) from Argentinean water buffaloesSilvina S Maidana, José L Konrad, María I Craig, et al.
Medical Care|April 5, 2008
Measuring clinically significant chemotherapy-related toxicities using Medicare claims from Cancer and Leukemia Group B (CALGB) trial participantsElizabeth B Lamont, James E Herndon, Jane C Weeks, et al.
The Journal of Infection|January 1, 1982
Rotavirus infections in a special-care baby unitA S Bryden, M E Thouless, C J Hall, et al.
Journal of the National Cancer Institute|September 21, 2006
Measuring disease-free survival and cancer relapse using Medicare claims from CALGB breast cancer trial participants (companion to 9344)Elizabeth B Lamont, James E Herndon, Jane C Weeks, et al.
Australian and New Zealand Journal of Medicine|June 1, 1991
Can the response to interferon treatment be predicted in patients with chronic active hepatitis C?R Lin, M N Schoeman, P I Craig, et al.
Gastrointestinal Endoscopy|September 27, 2017
Role of capsule endoscopy and fecal biomarkers in small-bowel Crohn's disease to assess remission and predict relapseVipul Aggarwal, Andrew S Day, Susan Connor, et al.
Pageof 20